Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Cisplatin and Capecitabine in Advanced Gastric Cancer
NCT00842491Phase 2Completed
- Sponsor
- Peking University
- Start
- Nov 2008
- Primary completion
- Apr 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in gastric cancer (GC), sponsored by Peking University. Started Nov 2008; status: completed.
02
Drugs
endostar
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00842491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842491.